Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pindolol for ventricular arrhythmia

P J Podrid, B Lown

    American Heart Journal
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Pindolol shows limited effectiveness for ventricular arrhythmia in coronary heart disease patients but is more beneficial for those without heart disease, particularly when exercise triggers arrhythmia. Acute drug testing accurately predicts long-term response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ventricular Tachycardia in the Young Athlete: A Systematic Approach to Selection of Drug Therapy.

    The Physician and sportsmedicine·2016
    Same author

    ELECTRICAL TERMINATION OF ECTOPIC ARRHYTHMIAS.

    A listing of research in the cardiovascular field·2014
    Same author

    [Open letter to the president of the Spanish government on health professionals and the consequences of a possible war in Iraq].

    Gaceta sanitaria·2003
    Same author

    "Let me see if i have this right...": words that help build empathy.

    Annals of internal medicine·2001
    Same author

    Cardiology at the crossroads: challenges for India and lessons from the West.

    Indian heart journal·2001
    Same author

    Proarrhythmia, a serious complication of antiarrhythmic drugs.

    Current cardiology reports·2000
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Ventricular arrhythmia poses a significant clinical challenge.
    • Assessing the efficacy of beta-blockers like pindolol is crucial for patient management.

    Purpose of the Study:

    • To evaluate the efficacy of pindolol in treating ventricular arrhythmia.
    • To compare pindolol's effectiveness in patients with and without coronary heart disease.
    • To determine the predictive value of acute drug testing for maintenance therapy response.

    Main Methods:

    • 43 patients with ventricular arrhythmia underwent acute pindolol testing and 3-day maintenance therapy.
    • Efficacy was assessed using ambulatory monitoring and treadmill exercise testing.
    • Patients were categorized based on the presence of coronary heart disease or no heart disease.

    Related Experiment Videos

    Main Results:

    • 50% of patients responded to acute pindolol testing.
    • Acute testing results correlated highly with maintenance therapy outcomes (81-88% concordance).
    • Pindolol suppressed arrhythmia during exercise in 53% of patients, with higher efficacy in those without heart disease (80%) compared to those with coronary heart disease (50%).

    Conclusions:

    • Pindolol is marginally effective for ventricular arrhythmia in coronary heart disease patients.
    • Pindolol appears more valuable for patients without heart disease, especially when arrhythmia is exercise-induced.
    • Acute drug testing is a valuable, rapid screening tool for identifying potential pindolol responders.